Track topics on Twitter Track topics that are important to you
HOUSTON, TX -- (Marketwired) -- 06/08/15 -- Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) today announced the launch of its surgical assist ancillary service line. With the recent launch of Nobilis' intraoperative monitoring services, surgical assist represents the second ancillary services revenue stream that Nobilis has added this quarter.
"The addition of surgical assistants at our current facilities, starting in Houston, allow our surgeons and facilities to operate more safely and efficiently, thus increasing our facilities' capacity as well as their ability to perform complex procedures," said Kenneth Efird, Nobilis' Chief Development Officer. "Like our intraoperative monitoring services, this service line complements our current facilities' operations while allowing Nobilis to capture additional per case revenue. A third party will handle staffing and administrative matters associated with this service line's operation, thus minimizing the administrative burden on Nobilis. This provider has the ability to continue providing services as Nobilis expands and grows organically," explained Dr. Efird.
"With this launch, Nobilis furthers its stated goal of expanding our ability to capture additional revenue related to our current facility operations," said Chris Lloyd, Nobilis' Chief Executive Officer, "Surgical assistants can be seamlessly added to our current facility operations, and by electing to outsource the administrative burdens, we can remain focused on our core business while enjoying the dual benefits of increased facility efficiency and additional per case revenue. We intend to add similarly complementary service lines in the near future."
About Nobilis Health Corp. Nobilis owns and manages ambulatory and acute care facilities to deliver healthcare services. Our focus is improving access to care and patient outcomes by providing minimally invasive procedures that can be performed in low-cost, outpatient settings. We utilize innovative direct-to-patient marketing and proprietary technologies to drive patient engagement and education. Nobilis owns and manages seven surgical facilities in Dallas, Houston, and Scottsdale and has contractual partnerships with six other facilities in Arizona, Oregon, Michigan, Minnesota, Tennessee and New Jersey.
Forward-Looking Statements This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com and in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2014, filed on April 2, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...